Evaluation of the Antibiofilmogramme Test During Orthopaedic Device-Related Infection
NCT03263832 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2021-03-02
Summary
This is an observational study that does not change routine care.
The primary objective of this study is to investigate the correlation between the administration of an antibiotherapy able to prevent biofilm formation according to the results of the Antibiofilmogramme test, and the relapse of the infection for patient with orthopaedic device-related infection.
Conditions
- Prosthetic Joint Infection
- Staphylococcus Aureus
- Biofilm
Interventions
- DIAGNOSTIC_TEST
-
Antibiofilmogramme
An Antibiofilmogramme (BioFilm Control) evaluates the capacity of a series of antibiotics to inhibit the growth of bacterial biofilms for a given bacterial isolate.
Sponsors & Collaborators
-
Hospices Civils de Lyon
collaborator OTHER -
BioFilm Control
lead INDUSTRY
Principal Investigators
-
Frederic Laurent, PharmD - PhD · Hospices Civils de Lyon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-01
- Primary Completion
- 2018-02-28
- Completion
- 2021-12-01
Countries
- France
Study Locations
More Related Trials
-
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT05181163 ·Status: UNKNOWN
-
Clinical Evaluation of Daptomycin Bone Penetration
NCT01306825 ·Status: UNKNOWN
-
Short Against Long Antibiotic Therapy for Infected Orthopedic Sites
NCT05499481 ·Status: COMPLETED ·Phase: PHASE3
-
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
NCT03209934 ·Status: COMPLETED
-
Bacterial Colonization on Nails Covered With a Methacrylic Coating
NCT06831305 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Staphylococcus Lugdunensis Prosthetic Joint Infection
NCT04409392 ·Status: COMPLETED
-
Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection
NCT03850860 ·Status: COMPLETED
-
Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
NCT07335627 ·Status: RECRUITING
-
Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections
NCT03403608 ·Status: COMPLETED
-
Tedizolid Suppressive Antimicrobial Therapy in a Reference Center
NCT04662736 ·Status: COMPLETED
-
Or v IV Antibiotics for Infection
NCT04723940 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin
NCT03246360 ·Status: COMPLETED ·Phase: NA
-
Analysis of Microbial Biofilms in Peripheral Venous Catheters and Their Implication in Infectious Risk
NCT07258862 ·Status: NOT_YET_RECRUITING
-
Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation
NCT06214403 ·Status: WITHDRAWN ·Phase: PHASE2
-
Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis
NCT02123628 ·Status: COMPLETED ·Phase: PHASE4
-
LocalVancomycinPowderToPreventPeriprostheticJointInfection.
NCT05697965 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Oral Antibiotics on Synovial Fluid and Differential for the Diagnosis of Infection
NCT03551847 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization
NCT00288418 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.
NCT07301294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
NCT03848104 ·Status: COMPLETED
-
Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
NCT01757236 ·Status: UNKNOWN ·Phase: PHASE2
-
Tedizolid Prolonged Treatment for Prosthetic Joint Infections
NCT03378427 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application
NCT00621114 ·Status: COMPLETED ·Phase: NA
-
Reduction of Antibiotherapy Duration for Infections on Implantable Extra Cardiac Devices Leads
NCT06203769 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections
NCT06089044 ·Status: COMPLETED